je.st
news
Tag: advanced
WideArray(TM) Edge Detectors Feature Advanced Technology
2015-09-28 12:31:15| Industrial Newsroom - All News for Today
WideArray edge detectors have continued to be enhanced with advanced technology. Madison, Wis. WideArray Edge Detectors from AccuWeb were introduced over fifteen years ago with its patented technology allowing for fully compensated, self-adjusting edge detection that could overcome ambient dust, changes in...
Tags: advanced
technology
feature
edge
Air Products to Highlight the Capabilities of an Advanced Node Copper Barrier Slurry at ICPT Conference
2015-09-28 12:31:15| Industrial Newsroom - All News for Today
Copper Barrier Slurries Offer Device Makers Erosion Improvement and Reduced Defects LEHIGH VALLEY, Pa. - Air Products (NYSE: APD) will feature its advanced copper barrier slurries for the electronics industry at the International Conference on Planarization Technology (ICPT), being held at the Wild Pass Horse Hotel...
Tags: advanced
products
air
conference
Ringdale Announces the Most Advanced Energy Monitor and Data Logger for Single- or Three-Phase Power Systems
2015-09-28 12:31:15| Industrial Newsroom - All News for Today
CT Energy Monitor and Data Logger Gives Companies Superior Insight and Control over Energy Conservation Initiatives GEORGETOWN, Texas, - Ringdale Inc., a Texas-based manufacturer of USA-made solid-state technologies, including ActiveLED luminaries, announces its CT Energy Monitor and Data Logger with Ethernet...
Tags: data
advanced
power
single
Rayonier Advanced Materials Announces Major Contract Extension
2015-09-28 06:09:46| chemicalonline Home Page
Rayonier Advanced Materials Inc.,announced today that, on Sept. 18, the Company amended its existing agreement with Nantong Cellulose Fibers Company (NCFC), its second largest customer, and extended the term of the agreement through calendar year 2019
Tags: advanced
major
materials
contract
New Findings Show Anti-Tumor Activity of KEYTRUDA (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
2015-09-26 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYTRUDA Monotherapy Achieved Overall Response Rate of 22.2 Percent in Previously-Treated Patients Results from KEYNOTE-028 Presented at 2015 European Cancer Congress KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, as a monotherapy in patients with advanced unresectable nasopharyngeal carcinoma (NPC) a type of head and neck cancer whose tumors express PD-L1 (1% of cells in tumor nests or PD-L1+ bands in stroma). Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558An Phan, (908) 255-6325orInvestor:Justin Holko, (908) 740-1879Teri Loxam, (908) 740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: show
advanced
activity
patients
Sites : [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] next »